Immediate Restoration of a New Implant With High Primary Stability (NCT07498556) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Immediate Restoration of a New Implant With High Primary Stability
Portugal50 participantsStarted 2026-07-01
Plain-language summary
The main objective of this scientific study is to evaluate the short-term (1-year) survival and success rates of dental implants restored immediately compared to implants restored after a three-month healing period.
The total duration of the study is 12 months following implant placement, during which clinical and radiographic evaluations will be carried out at different follow-up time points.
Who can participate
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men and women between 18 and 70 years of age.
* Ability to read, understand, and sign the informed consent form.
* Need for placement of one or more implants for fixed prosthetic rehabilitation in either arch.
* Insertion torque ≥ 35 Ncm (lower values will be excluded from the study).
* Adequate bone dimensions to receive an implant with diameter ≥ 3.75 mm and length ≥ 10 mm.
* Bone type I to III at the insertion site.
* Good oral hygiene: FMBS and FMPS ≤ 25%.
* Systemic status classified as ASA I or II.
Exclusion Criteria:
* Inability to attend follow-up appointments.
* Systemic contraindications to oral surgery (ASA III or IV).
* Pregnancy or breastfeeding.
* Chronic use of corticosteroids, bisphosphonates, or RANKL inhibitors within the last year.
* Alcohol or drug abuse.
* Heavy smoking (≥ 10 cigarettes/day).
* Previous radiotherapy in the cervicofacial region.
* Untreated active periodontal disease.
* Absence of antagonist teeth.
* Local pathology at the planned implant site.
* Uncontrolled diabetes mellitus (HbA1c \> 7%).
* Bone type IV at the surgical site.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.